AKESF
Price
$7.19
Change
-$0.06 (-0.83%)
Updated
Jan 10 closing price
Capitalization
7.22B
BNTX
Price
$115.25
Change
-$2.00 (-1.71%)
Updated
Jan 22, 04:59 PM (EDT)
Capitalization
27.61B
46 days until earnings call
Ad is loading...

AKESF vs BNTX

Header iconAKESF vs BNTX Comparison
Open Charts AKESF vs BNTXBanner chart's image
AKESO
Price$7.19
Change-$0.06 (-0.83%)
Volume$6K
Capitalization7.22B
BioNTech SE American Depositary Share
Price$115.25
Change-$2.00 (-1.71%)
Volume$7.73K
Capitalization27.61B
AKESF vs BNTX Comparison Chart
Loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKESF vs. BNTX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and BNTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (AKESF: $7.19 vs. BNTX: $115.17)
Brand notoriety: AKESF and BNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 191% vs. BNTX: 73%
Market capitalization -- AKESF: $7.22B vs. BNTX: $27.61B
AKESF [@Biotechnology] is valued at $7.22B. BNTX’s [@Biotechnology] market capitalization is $27.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileBNTX’s FA Score has 2 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • BNTX’s FA Score: 2 green, 3 red.
According to our system of comparison, BNTX is a better buy in the long-term than AKESF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKESF’s TA Score shows that 3 TA indicator(s) are bullish while BNTX’s TA Score has 4 bullish TA indicator(s).

  • AKESF’s TA Score: 3 bullish, 2 bearish.
  • BNTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than AKESF.

Price Growth

AKESF (@Biotechnology) experienced а 0.00% price change this week, while BNTX (@Biotechnology) price change was +1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +2.32%, and the average quarterly price growth was -2.48%.

Reported Earning Dates

BNTX is expected to report earnings on May 05, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($27.6B) has a higher market cap than AKESF($7.22B). BNTX has higher P/E ratio than AKESF: BNTX (161.76) vs AKESF (25.37). AKESF YTD gains are higher at: 2.714 vs. BNTX (1.071).
AKESFBNTXAKESF / BNTX
Capitalization7.22B27.6B26%
EBITDAN/A-375.9M-
Gain YTD2.7141.071254%
P/E Ratio25.37161.7616%
RevenueN/A3.04B-
Total CashN/A16.7B-
Total DebtN/A244M-
TECHNICAL ANALYSIS
Technical Analysis
AKESFBNTX
RSI
ODDS (%)
N/A
Bearish Trend 16 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 16 days ago
43%
Bearish Trend 16 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 16 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 16 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
28%
Bullish Trend 16 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
39%
Bullish Trend 16 days ago
76%
Advances
ODDS (%)
Bullish Trend 21 days ago
50%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 25 days ago
60%
N/A
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
50%
Bearish Trend 16 days ago
90%
Aroon
ODDS (%)
Bearish Trend 16 days ago
58%
N/A
View a ticker or compare two or three
Ad is loading...
AKESF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AQEIX18.350.11
+0.60%
LKCM Aquinas Catholic Equity
PEEAX15.940.05
+0.31%
PGIM Jennison Mid-Cap Growth A
VVJFX59.79-0.01
-0.02%
Voya Multi-Manager Intl Sm Cp R6
FFGAX18.75-0.14
-0.74%
Fidelity Advisor Global Commodity Stk A
VEVIX47.47-0.40
-0.84%
Victory Sycamore Established Value I

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
N/A
INBX - AKESF
45%
Loosely correlated
-4.16%
SMMT - AKESF
27%
Poorly correlated
+6.43%
NUVL - AKESF
25%
Poorly correlated
+3.88%
BNTX - AKESF
23%
Poorly correlated
-1.77%
CPMV - AKESF
22%
Poorly correlated
N/A
More

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.77%
MRNA - BNTX
49%
Loosely correlated
+7.27%
TIL - BNTX
44%
Loosely correlated
+0.56%
CVAC - BNTX
44%
Loosely correlated
-4.35%
AXON - BNTX
43%
Loosely correlated
+0.33%
ARCT - BNTX
38%
Loosely correlated
+2.01%
More